Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.1200
+0.0050 (4.17%)
Jan 13, 2026, 3:20 PM AEST
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of 39.13 million as of January 13, 2026. Its market cap has increased by 72.46% in one year.
Market Cap
39.13M
Enterprise Value
38.75M
Revenue
3.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has increased from 32.74M to 39.13M, an increase of 19.50%. That is a compound annual growth rate of 2.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 39.13M | -11.11% |
| Dec 31, 2025 | 44.02M | 78.41% |
| Dec 31, 2024 | 24.67M | -17.35% |
| Dec 29, 2023 | 29.85M | -86.11% |
| Dec 30, 2022 | 215.00M | -33.62% |
| Dec 31, 2021 | 323.86M | 83.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.02B |
| Pro Medicus | 21.96B |
| Cochlear | 17.22B |
| Sonic Healthcare | 11.07B |
| Ramsay Health Care | 8.13B |
| Ansell | 4.77B |
| Mesoblast | 3.94B |
| Telix Pharmaceuticals | 3.81B |